This study has shown that LYVE-1 is a heterogeneous marker for both lymphatic, arterial and venous endothelial cells.
There is also a significant decrease of LYVE-1 expression in EOPE+.
LYVE-1 immuno-expression was significantly elevated in the conducting compared to the exchange villi.